fullerene c60 has been researched along with oligonucleotides in 4 studies
Studies (fullerene c60) | Trials (fullerene c60) | Recent Studies (post-2010) (fullerene c60) | Studies (oligonucleotides) | Trials (oligonucleotides) | Recent Studies (post-2010) (oligonucleotides) |
---|---|---|---|---|---|
3,806 | 5 | 2,170 | 23,128 | 245 | 7,331 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Z; Li, B; Meng, X; Tan, X; Yang, X; Yu, Q; Zhao, D | 1 |
Joseph, J; Saraswathi, SK; Vittala, SK | 1 |
Cheng, Z; Li, H; Li, Y; Li, Z; Shi, J; Xiao, Y; Xiong, J; Zhang, B; Zhang, K | 1 |
Äärelä, A; Holm, P; Räsänen, K; Salo, H; Virta, P | 1 |
4 other study(ies) available for fullerene c60 and oligonucleotides
Article | Year |
---|---|
Inhibition of in vitro amplification of targeted DNA fragment and activity of exonuclease I by a fullerene-oligonucleotide conjugate.
Topics: DNA; Dose-Response Relationship, Drug; Enzyme Inhibitors; Exodeoxyribonucleases; Fullerenes; Gene Amplification; Gene Silencing; HeLa Cells; Humans; Models, Biological; Oligodeoxyribonucleotides; Oligonucleotides; Polymerase Chain Reaction; Reactive Oxygen Species | 2008 |
Fullerene Cluster Assisted Self-Assembly of Short DNA Strands into Semiconducting Nanowires.
Topics: Fullerenes; Hydrophobic and Hydrophilic Interactions; Microscopy, Atomic Force; Nanostructures; Nanowires; Nucleic Acid Conformation; Oligonucleotides; Particle Size; Semiconductors; Temperature | 2017 |
Well-Defined DNA-Polymer Miktoarm Stars for Enzyme-Resistant Nanoflares and Carrier-Free Gene Regulation.
Topics: Cell Line, Tumor; DNA; Fullerenes; Humans; Models, Molecular; Molecular Conformation; Nanostructures; Nucleic Acid Hybridization; Oligonucleotides; Polyethylene Glycols | 2020 |
Synthesis of Site-Specific Antibody-[60]Fullerene-Oligonucleotide Conjugates for Cellular Targeting.
Topics: Antibodies; Fullerenes; Humans; Immunoconjugates; Oligonucleotides | 2023 |